Home › NDC Lookup › RxCUI directory › RxCUI 311376

Lorazepam 2 MG/ML Oral Solution — RxCUI 311376

RxNorm drug concept · Semantic clinical drug
RxCUI 311376 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI311376
Official nameLorazepam 2 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslorazepam 2 MG per 1 ML Concentrate for Oral Solution; LORazepam 2 MG in 1 mL Concentrate for Oral Solution
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)13,208 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lorazepam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Lorazepam is mainly prescribed for anxiety disorders — it can calm anxious feelings and physical tension, especially for short periods. In tablet or liquid form, it's used for ongo...
  • Yes, drowsiness is one of the most common effects — and for many people that's actually part of how it helps with anxiety. You may also notice some unsteadiness, dizziness, or mild...
  • Will lorazepam make me feel really drowsy?
  • No — please avoid alcohol completely while you're on lorazepam. Both alcohol and lorazepam slow down your central nervous system, and together they can make that effect dangerously...
📖 Read our full Lorazepam guide →

🕸️ Concept Web — How Lorazepam 2 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lorazepam 2 MG/ML Oral Solution RxCUI 311376

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lorazepam 6470
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lorazepam Oral Solution 372644
    • Lorazepam Oral Liquid Product 1165339
    • Lorazepam Oral Product 1165340
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Lorazepam 2 MG/ML 316171

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lorazepam 2 MG/ML SCDC · 316171
  • Lorazepam Oral Solution SCDF · 372644
  • Lorazepam Oral Liquid Product SCDG · 1165339
  • Lorazepam Oral Product SCDG · 1165340

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 311376 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-3532-44 1 BOTTLE in 1 CARTON (0054-3532-44) / 30 mL in 1 BOTTLE Lorazepam Hikma Pharmaceuticals USA Inc. 1991-06-28
00121-0770-01 1 BOTTLE, DROPPER in 1 CARTON (0121-0770-01) / 30 mL in 1 B... Lorazepam Pharmaceutical Associates, Inc. 2010-11-01
62135-0549-43 30 mL in 1 BOTTLE (62135-549-43) Lorazepam Chartwell RX, LLC 2023-04-20
65162-0687-84 30 mL in 1 BOTTLE, DROPPER (65162-687-84) Lorazepam Amneal Pharmaceuticals LLC 2010-02-01
Observed labelers: Amneal Pharmaceuticals LLC (1) · Chartwell RX, LLC (1) · Hikma Pharmaceuticals USA Inc. (1) · Pharmaceutical Associates, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.